Suppr超能文献

德克萨斯州东北部主要为农村地区未参保或参保不足人群的免费结直肠癌筛查测试的投资回报率

Return on Investment of Free Colorectal Cancer Screening Tests in a Primarily Rural Uninsured or Underinsured Population in Northeast Texas.

作者信息

Orsak Gabriela, Miller Anastasia, Allen Carlton M, Singh Karan P, McGaha Paul

机构信息

Department of Epidemiology and Biostatistics, School of Rural and Community Health, The University of Texas Health Science Center at Tyler, 11937 US HWY 271, Tyler, TX, 75708-3154, USA.

Department of Healthcare Policy, Economics and Management, The University of Texas Health Science Center at Tyler, Tyler, TX, USA.

出版信息

Pharmacoecon Open. 2020 Mar;4(1):71-77. doi: 10.1007/s41669-019-0147-y.

Abstract

BACKGROUND

Colorectal cancer (CRC) is the third most common cancer in the USA. Its economic impact is extensive, and preventive screening services are warranted to help prevent it.

OBJECTIVE

We sought to examine the return on investment, in terms of reduced costs attributed to cancer prevention, of a CRC screening outreach program providing education and screening in a primarily rural region targeting the uninsured and underinsured.

METHODS

The expenditures of the Northeast Texas CRC screening program were calculated for the years of 2016 and 2017. Prices ($US) were adjusted for inflation and converted to year 2017 values. The costs saved were calculated using the estimated costs of CRC care present in the literature.

RESULTS

For fiscal years 2016 and 2017, the program provided an average return of $US1.46-2.06 for every tax dollar spent. Estimated cost avoidance was $US165,080 per avoided case and estimated cost avoidance of $US245,601 among early-stage cancer cases detected, resulting in potential savings ranging from $US3,893,676 to $US4,837,923.

CONCLUSION

A CRC outreach program providing education and screening operating in less densely populated regions yields a positive return on investment.

摘要

背景

结直肠癌(CRC)是美国第三大常见癌症。其经济影响广泛,因此有必要开展预防性筛查服务以帮助预防该病。

目的

我们试图评估一项在主要为农村地区针对未参保和参保不足人群开展教育及筛查的结直肠癌筛查推广项目在癌症预防成本降低方面的投资回报率。

方法

计算了2016年和2017年德克萨斯州东北部结直肠癌筛查项目的支出。价格(美元)经通胀调整后换算为2017年的价值。使用文献中结直肠癌治疗的估计成本计算节省的成本。

结果

在2016财年和2017财年,该项目每花费1美元税收平均回报为1.46 - 2.06美元。每避免一例病例估计节省成本165,080美元,在检测出的早期癌症病例中估计节省成本245,601美元,潜在节省金额在3,893,676美元至4,837,923美元之间。

结论

在人口密度较低地区开展教育及筛查的结直肠癌推广项目产生了正投资回报率。

相似文献

2
Calculating the return on investment of mobile healthcare.
BMC Med. 2009 Jun 2;7:27. doi: 10.1186/1741-7015-7-27.
5
The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence.
Tob Use Insights. 2015 Jul 14;8:1-35. doi: 10.4137/TUI.S15628. eCollection 2015.
6
Return on Investment Analysis of Breast Cancer Screening and Downstaging in Egypt: Implications for Developing Countries.
Value Health Reg Issues. 2018 Sep;16:22-27. doi: 10.1016/j.vhri.2018.01.006. Epub 2018 Apr 4.
8
Does National Colorectal Cancer Screening Program Represent Good Value for Money? Results from a Return-on-Investment Model in Vietnam.
Health Serv Insights. 2021 May 24;14:11786329211017418. doi: 10.1177/11786329211017418. eCollection 2021.
9
Cost Analysis of Free Colonoscopies in an Uninsured Population at Increased Risk for Colorectal Cancer.
J Am Coll Surg. 2016 Jul;223(1):129-32. doi: 10.1016/j.jamcollsurg.2016.04.035. Epub 2016 May 26.
10
Colorectal neoplasia prevalence in a predominantly Hispanic community: Results from a colorectal cancer screening program in Texas.
Am J Med Sci. 2022 Oct;364(4):394-403. doi: 10.1016/j.amjms.2022.03.013. Epub 2022 Apr 6.

引用本文的文献

1
Artificial Intelligence Can Cut Costs While Maintaining Accuracy in Colorectal Cancer Genotyping.
Front Oncol. 2021 Jun 8;11:630953. doi: 10.3389/fonc.2021.630953. eCollection 2021.
2
Does National Colorectal Cancer Screening Program Represent Good Value for Money? Results from a Return-on-Investment Model in Vietnam.
Health Serv Insights. 2021 May 24;14:11786329211017418. doi: 10.1177/11786329211017418. eCollection 2021.

本文引用的文献

1
Rapid review of factors associated with flexible sigmoidoscopy screening use.
Prev Med. 2019 Mar;120:8-18. doi: 10.1016/j.ypmed.2018.12.018. Epub 2018 Dec 28.
2
Anxiety Associated with Colonoscopy and Flexible Sigmoidoscopy: A Systematic Review.
Am J Gastroenterol. 2018 Dec;113(12):1810-1818. doi: 10.1038/s41395-018-0398-8. Epub 2018 Nov 1.
3
Rural-Urban Disparities in Time to Diagnosis and Treatment for Colorectal and Breast Cancer.
Cancer Epidemiol Biomarkers Prev. 2018 Sep;27(9):1036-1046. doi: 10.1158/1055-9965.EPI-18-0210. Epub 2018 Jul 9.
4
Return on Investment Analysis of Breast Cancer Screening and Downstaging in Egypt: Implications for Developing Countries.
Value Health Reg Issues. 2018 Sep;16:22-27. doi: 10.1016/j.vhri.2018.01.006. Epub 2018 Apr 4.
6
Financial Insolvency as a Risk Factor for Early Mortality Among Patients With Cancer.
J Clin Oncol. 2016 Mar 20;34(9):980-6. doi: 10.1200/JCO.2015.64.6620. Epub 2016 Jan 25.
7
The role of virtual colonoscopy in colorectal screening.
Clin Imaging. 2016 Mar-Apr;40(2):315-20. doi: 10.1016/j.clinimag.2015.07.009. Epub 2015 Jul 16.
8
Colorectal cancer screening: a global overview of existing programmes.
Gut. 2015 Oct;64(10):1637-49. doi: 10.1136/gutjnl-2014-309086. Epub 2015 Jun 3.
9
Multitarget stool DNA testing for colorectal-cancer screening.
N Engl J Med. 2014 Apr 3;370(14):1287-97. doi: 10.1056/NEJMoa1311194. Epub 2014 Mar 19.
10
Geographic residency status and census tract socioeconomic status as determinants of colorectal cancer outcomes.
Am J Public Health. 2014 Mar;104(3):e63-71. doi: 10.2105/AJPH.2013.301572. Epub 2014 Jan 16.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验